{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T11:06:17Z","timestamp":1768647977468,"version":"3.49.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,5,18]],"date-time":"2012-05-18T00:00:00Z","timestamp":1337299200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-244x-12-43","type":"journal-article","created":{"date-parts":[[2012,5,21]],"date-time":"2012-05-21T04:07:15Z","timestamp":1337573235000},"source":"Crossref","is-referenced-by-count":19,"title":["Sibutramine-induced mania as the first manifestation of bipolar disorder"],"prefix":"10.1186","volume":"12","author":[{"given":"Napoleon","family":"Waszkiewicz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"Zalewska-Szajda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u0142awomir Dariusz","family":"Szajda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Simonienko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Zalewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agata","family":"Szulc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerzy Robert","family":"\u0141adny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Zwierz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,5,18]]},"reference":[{"key":"994_CR1","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1467-789X.2007.00425.x","volume":"9","author":"M Florentin","year":"2008","unstructured":"Florentin M, Liberopoulos EN, Elisaf MS: Sibutramine-associated adverse effects: a practical guide for its safe use. Obes Rev. 2008, 9: 378-387. 10.1111\/j.1467-789X.2007.00425.x.","journal-title":"Obes Rev"},{"key":"994_CR2","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/j.1755-5949.2010.00172.x","volume":"5","author":"PJ Nathan","year":"2011","unstructured":"Nathan PJ, O'Neill BV, Napolitano A, Bullmore ET: Neuropsychiatric adverse effects of centrally acting antiobesity drugs. CNS Neurosci Ther. 2011, 5: 490-505.","journal-title":"CNS Neurosci Ther"},{"key":"994_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0140-6736(07)60033-6","volume":"369","author":"RS Padwal","year":"2007","unstructured":"Padwal RS, Majumdar SR: Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Lancet. 2007, 369: 71-77. 10.1016\/S0140-6736(07)60033-6.","journal-title":"Lancet"},{"key":"994_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jpsychores.2007.05.014","volume":"64","author":"J Lee","year":"2008","unstructured":"Lee J, Teoh T, Lee TS: Catatonia and psychosis associated with sibutramine: A case report and pathophysiologic correlation. J Psychosom Res. 2008, 64: 107-109. 10.1016\/j.jpsychores.2007.05.014.","journal-title":"J Psychosom Res"},{"key":"994_CR5","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1176\/appi.ajp.157.12.2057","volume":"157","author":"T Tali\u0144ski","year":"2000","unstructured":"Tali\u0144ski T, Chojnacka J: Sibutramine-associated psychotic episode. Am J Psych. 2000, 157: 2057-2058. 10.1176\/appi.ajp.157.12.2057.","journal-title":"Am J Psych"},{"key":"994_CR6","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jpsychores.2008.09.013","volume":"65","author":"B Dogangun","year":"2008","unstructured":"Dogangun B, Bolat N, Rustamov I, Kayaalp L: Sibutramine-induced psychotic episode in an adolescent. J Psychosom Res. 2008, 65: 505-506. 10.1016\/j.jpsychores.2008.09.013.","journal-title":"J Psychosom Res"},{"key":"994_CR7","first-page":"671","volume":"136","author":"CRA Figueroa","year":"2008","unstructured":"Figueroa CRA, Casta\u00f1o CC: Sibutramine associated psychotic episode: a case report. Rev Med Chil. 2008, 136: 671-673.","journal-title":"Rev Med Chil"},{"key":"994_CR8","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.pnpbp.2010.07.009","volume":"34","author":"S Naik","year":"2010","unstructured":"Naik S, Khoo CL, Lua R, Chai SB, Liew A, Sim K: Recurrent episodes of brief affective psychosis induced by sibutramine. Prog Neuropsychopharmacol Biol Psychiatry. 2010, 34: 1359-1360. 10.1016\/j.pnpbp.2010.07.009.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"994_CR9","first-page":"218","volume":"106","author":"D M\u00fcller","year":"2009","unstructured":"M\u00fcller D, Weinmann W, Hermanns-Clausen M: Chinese slimming capsules containing sibutramine sold over the Internet: a case series. Dtsch Arztebl Int. 2009, 106: 218-222.","journal-title":"Dtsch Arztebl Int"},{"key":"994_CR10","first-page":"64","volume":"44","author":"S Fiorentini","year":"2009","unstructured":"Fiorentini S, Russo D, D'Amato A, Limpido L, Bersani G: Sibutramine-related panic attack: a clinical case of apparent resolution with paroxetine. Riv Psichiatr. 2009, 44: 64-67.","journal-title":"Riv Psichiatr"},{"key":"994_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1176\/jnp.2007.19.1.88","volume":"19","author":"P Fernandez","year":"2007","unstructured":"Fernandez P, Peiro AM: A sibutramine-induced delusional disorder relapse. J Neuropsychiatry Clin Neurosci. 2007, 19: 88-89. 10.1176\/appi.neuropsych.19.1.88.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"994_CR12","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/NRL.0b013e3181c6bf1b","volume":"16","author":"PK Fu","year":"2010","unstructured":"Fu PK, Hsu HY, Wang PY: Transient global amnesia after taking sibutramine: a case report. Neurologist. 2010, 16: 129-131. 10.1097\/NRL.0b013e3181c6bf1b.","journal-title":"Neurologist"},{"key":"994_CR13","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1590\/S1516-44462008000400018","volume":"30","author":"FF Rocha","year":"2008","unstructured":"Rocha FF, Bamberg TO, Pinto FC, Gomes LM, Silveira S: Hypomanic episode secondary to sibutramine in a patient with type-I bipolar disorder. Rev Bras Psiquiatr. 2008, 30: 400-401. 10.1590\/S1516-44462008000400018.","journal-title":"Rev Bras Psiquiatr"},{"key":"994_CR14","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1017\/S1461145702003000","volume":"5","author":"Q Cordeiro","year":"2002","unstructured":"Cordeiro Q, Vallada H: Sibutramine-induced mania episode in a bipolar patient. Int J Neuropsychopharmacol. 2002, 5: 283-284.","journal-title":"Int J Neuropsychopharmacol"},{"key":"994_CR15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.4088\/JCP.v63n0213a","volume":"63","author":"F Benazzi","year":"2002","unstructured":"Benazzi F: Organic hypomania secondary to sibutramine-citalopram interaction. J Clin Psychiatry. 2002, 63: 165-10.4088\/JCP.v63n0213a.","journal-title":"J Clin Psychiatry"},{"key":"994_CR16","first-page":"129","volume":"13","author":"MC Eker","year":"2003","unstructured":"Eker MC, Onat O, Pirildar S, Ozaskinli S: Case report: A mixed episode induced by Sibutramine. Klin Psikofarmacol Bul. 2003, 13: 129-132.","journal-title":"Klin Psikofarmacol Bul"},{"key":"994_CR17","first-page":"335","volume":"4","author":"T Binbay","year":"2010","unstructured":"Binbay T: First-episode mania with psychotic features induced by over-the-counter diet aids containing sibutramine. Turk Psikiyatri Derg. 2010, 4: 335-337.","journal-title":"Turk Psikiyatri Derg"},{"key":"994_CR18","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1046\/j.1399-5618.2003.00067.x","volume":"5","author":"JF Goldberg","year":"2003","unstructured":"Goldberg JF, Truman CJ: Antidepressant-induced mania: an overview of current controversies. Bipolar Disord. 2003, 5: 407-420. 10.1046\/j.1399-5618.2003.00067.x.","journal-title":"Bipolar Disord"},{"key":"994_CR19","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/j.1399-5618.2010.00864.x","volume":"12","author":"FM Daray","year":"2010","unstructured":"Daray FM, Thommi SB, Ghaemi SN: The pharmacogenetics of antidepressant-induced mania: a systematic review and meta-analysis. Bipolar Disord. 2010, 12: 702-706. 10.1111\/j.1399-5618.2010.00864.x.","journal-title":"Bipolar Disord"},{"key":"994_CR20","unstructured":"Waszkiewicz N, Szulc A: An intellectual construct of bipolarity diagnosis. http:\/\/www.bmj.com\/rapid-response\/2011\/11\/03\/intellectual-construct-bipolarity-diagnosis ,"},{"key":"994_CR21","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jad.2008.04.012","volume":"112","author":"AdA Ferreira","year":"2009","unstructured":"Ferreira AdA, Neves FS, da Rocha FF, Silva GSe, Romano-Silva MA, Miranda DM, De Marco L, Correa H: The role of 5-HTTLPR polymorphism in antidepressant-associated mania in bipolar disorder. J Affect Disord. 2009, 112: 267-272. 10.1016\/j.jad.2008.04.012.","journal-title":"J Affect Disord"},{"key":"994_CR22","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/j.1399-5618.2007.00488.x","volume":"9","author":"SL McElroy","year":"2007","unstructured":"McElroy SL, Frye MA, Altshuler LL, Suppes T, Hellemann G, Black D, Mintz J, Kupka R, Nolen W, Leverich GS, Denicoff KD, Post RM, Keck PE: A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders. Bipolar Disord. 2007, 9: 426-434. 10.1111\/j.1399-5618.2007.00488.x.","journal-title":"Bipolar Disord"},{"key":"994_CR23","unstructured":"European Medicines Agency: Press release 21 January. http:\/\/www.ema.europa.eu\/pdfs\/human\/referral\/sibutramine\/3940810en.pdf ,"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-12-43.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-244X-12-43\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-12-43","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T21:26:46Z","timestamp":1468358806000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/1471-244X-12-43"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,18]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["994"],"URL":"https:\/\/doi.org\/10.1186\/1471-244x-12-43","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,18]]},"article-number":"43"}}